CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Piramal Pharma Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Piramal Pharma Ltd
Phone: +91 223802300p:+91 223802300 MUMBAI, 400070  India Ticker: PPLPHARMAPPLPHARMA
Business Summary
Piramal Pharma Limited is a global pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. It operates approximately 17 development and manufacturing facilities across India, UK/Europe, and North America. It has a commercial presence in over 100 countries. The Company operates under three business verticals: Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organization (CDMO); Piramal Critical Care (PCC), a Complex Hospital Generics (CHG) business; and India Consumer Healthcare (ICH) business, selling over-the-counter (OTC) products. PPS caters to both drug substances - Active Pharmaceutical Ingredients (APIs), and drug products (formulations). PCC's complex hospital product portfolio comprises over 35 hospital-focused products in the areas of inhalation anesthesia, injectable anesthesia and pain management, intrathecal therapy, and other generic and specialty products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Nandini A.Piramal 43 4/1/2021 3/4/2020
Chief Financial Officer, Executive Director VivekValsaraj 50 2/9/2022 2/9/2022
Compliance Officer, Company Secretary TanyaSanish
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Ash Stevens LLC 18655 Krause St Riverview MI United States

Business Names
Business Name
543635
Ash Stevens LLC
EQPPLPHARMA
Piramal Pharma Ltd
PPLPHARMA

General Information
Number of Employees: 6,719 (As of 3/31/2024)
Outstanding Shares: 1,320,421,481 (As of 12/31/2024)
Shareholders: 307,240
Stock Exchange: NSE


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025